FORMULATION, OPTIMIZATION, AND ESTIMATION OF CELECOXIB TOPICAL EMULGEL: A COMPREHENSIVE REVIEW

Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor widely prescribed for osteoarthritis, rheumatoid arthritis, and acute pain, is limited in its oral use by poor aqueous solubility, variable bioavailability, and a well-documented risk of gastrointestinal and cardiovascular adverse effects on chronic administration. Topical delivery of celecoxib offers an attractive alternative by directing the drug to the site of musculoskeletal or dermal pathology, minimizing systemic exposure, and improving patient acceptability. Among semisolid carriers, the emulgel — a biphasic system in which a fine emulsion is dispersed within a gel network — has emerged as a preferred vehicle for lipophilic, poorly water-soluble drugs such as celecoxib because it combines the drug-loading capacity of an emulsion with the spreadability, patient compliance, and dual-controlled release behavior of a gel. This review consolidates the current literature on celecoxib emulgel systems, covering the physicochemical and pharmacological rationale for topical delivery, the excipients and preparation methods used to formulate conventional, nano-, and microemulsion-based emulgels, the application of Quality by Design (QbD) and statistical design of experiments (Box-Behnken, central composite, and factorial designs) for formulation optimization, the standard panel of physicochemical, rheological, ex vivo, and stability evaluations applied to these systems, and the analytical (UV spectrophotometric and HPLC) methods used to estimate celecoxib in bulk, formulation, and biological matrices. Reported optimized celecoxib emulgels have consistently demonstrated acceptable pH, non-Newtonian pseudoplastic rheology, high drug content, and substantially enhanced ex vivo skin permeation and anti-inflammatory activity relative to conventional gels or marketed products. The review concludes by identifying persistent challenges — including long-term physical stability of the dispersed phase, scale-up reproducibility, and the need for harmonized in vitro-in vivo correlation — and outlines directions for future research in this field.